Jinhe Biotechnology Co Ltd (002688) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, Jinhe Biotechnology Co Ltd (002688) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥229.93 Million ≈ $33.65 Million USD) by net assets (CN¥2.60 Billion ≈ $380.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Jinhe Biotechnology Co Ltd for the company's overall valuation and market capitalisation.

Jinhe Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Jinhe Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jinhe Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jinhe Biotechnology Co Ltd ranked by their cash flow conversion efficiency. Explore Jinhe Biotechnology Co Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Selamat Sempurna Tbk JK:SMSM	0.072x
Yuanta Sec Kor KO:003470	-0.033x
Bar Harbor Bankshares Inc NYSE MKT:BHB	0.009x
Beijing Chunlizhengda Medical Instruments Co Ltd SHG:688236	0.011x
COGNYTE SOFTWARE LTD F:81M	-0.021x
RaySearch Laboratories AB (publ) ST:RAY-B	0.112x
Onterris NYSE:ONT	0.014x
Jensen-Group NV BR:JEN	0.102x

Annual Cash Flow Conversion Efficiency for Jinhe Biotechnology Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Jinhe Biotechnology Co Ltd from 2008 to 2024. View Jinhe Biotechnology Co Ltd (002688) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.50 Billion ≈ $365.81 Million	CN¥498.42 Million ≈ $72.94 Million	0.199x	+152.45%
2023-12-31	CN¥2.52 Billion ≈ $368.27 Million	CN¥198.77 Million ≈ $29.09 Million	0.079x	+53.88%
2022-12-31	CN¥2.43 Billion ≈ $354.89 Million	CN¥124.47 Million ≈ $18.21 Million	0.051x	-9.53%
2021-12-31	CN¥2.70 Billion ≈ $394.58 Million	CN¥152.98 Million ≈ $22.39 Million	0.057x	-61.53%
2020-12-31	CN¥1.75 Billion ≈ $256.07 Million	CN¥258.08 Million ≈ $37.77 Million	0.147x	-5.57%
2019-12-31	CN¥1.81 Billion ≈ $264.40 Million	CN¥282.19 Million ≈ $41.29 Million	0.156x	+137.16%
2018-12-31	CN¥1.78 Billion ≈ $260.38 Million	CN¥117.17 Million ≈ $17.15 Million	0.066x	+295.62%
2017-12-31	CN¥1.64 Billion ≈ $239.59 Million	CN¥27.25 Million ≈ $3.99 Million	0.017x	-90.98%
2016-12-31	CN¥1.58 Billion ≈ $231.81 Million	CN¥292.41 Million ≈ $42.79 Million	0.185x	-9.45%
2015-12-31	CN¥1.05 Billion ≈ $154.31 Million	CN¥214.97 Million ≈ $31.46 Million	0.204x	+435.95%
2014-12-31	CN¥956.13 Million ≈ $139.91 Million	CN¥-58.02 Million ≈ $-8.49 Million	-0.061x	-136.82%
2013-12-31	CN¥900.07 Million ≈ $131.71 Million	CN¥148.32 Million ≈ $21.70 Million	0.165x	+60.24%
2012-12-31	CN¥863.55 Million ≈ $126.36 Million	CN¥88.81 Million ≈ $13.00 Million	0.103x	-67.74%
2011-12-31	CN¥334.40 Million ≈ $48.93 Million	CN¥106.59 Million ≈ $15.60 Million	0.319x	-31.19%
2010-12-31	CN¥254.83 Million ≈ $37.29 Million	CN¥118.05 Million ≈ $17.27 Million	0.463x	+291.50%
2009-12-31	CN¥196.03 Million ≈ $28.69 Million	CN¥23.20 Million ≈ $3.39 Million	0.118x	+80.81%
2008-12-31	CN¥177.82 Million ≈ $26.02 Million	CN¥11.64 Million ≈ $1.70 Million	0.065x	--

About Jinhe Biotechnology Co Ltd

SHE:002688 China Drug Manufacturers - Specialty & Generic

Market Cap

$580.38 Million

CN¥3.97 Billion CNY

Market Cap Rank

#11575 Global

#3290 in China

Share Price

CN¥5.14

Change (1 day)

-0.58%

52-Week Range

CN¥4.62 - CN¥7.11

All Time High

CN¥10.94